₦ NGN
Language
Currency
‹ All headlines
ScienceDaily Health

Common antidepressant may ease long COVID’s crushing fatigue

1 week ago
A low-cost antidepressant may offer new hope for people struggling with long COVID fatigue. In a randomized clinical trial involving 399 adults, fluvoxamine significantly reduced fatigue and improved quality of life compared with a placebo, making it one of the first medications to show meaningful benefits for this disabling condition.
Get the EPELCON App v3.6.0
Invest, Learn & Earn on the go
Download APK
feedback Feedback